Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.05 TWD
115.78 M TWD
1.68 B TWD
90.12 M
About APEX BIOTECHNOLOGY CORP
Sector
Industry
CEO
Yan Shih Shen
Website
Headquarters
Hsinchu
Founded
1997
ISIN
TW0001733004
FIGI
BBG000BK0YZ9
Apex Biotechnology Corp. engages in the business of research, development, production, manufacturing, and selling biochemical testing instruments and detection strips; and trading relevant products and components. It operates through the following geographical segments: Taiwan, the United States of America, Italy, Austria, China, and Others. The company was founded on December 2, 1997 and is headquartered in Hsinchu, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 1733 is 30.00 TWD — it has increased by 0.67% in the past 24 hours. Watch APEX BIOTECHNOLOGY CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange APEX BIOTECHNOLOGY CORP stocks are traded under the ticker 1733.
1733 stock has risen by 3.45% compared to the previous week, the month change is a 2.92% rise, over the last year APEX BIOTECHNOLOGY CORP has showed a −23.08% decrease.
1733 reached its all-time high on Jul 25, 2007 with the price of 98.40 TWD, and its all-time low was 16.55 TWD and was reached on Oct 26, 2005. View more price dynamics on 1733 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1733 stock is 1.34% volatile and has beta coefficient of 0.48. Track APEX BIOTECHNOLOGY CORP stock price on the chart and check out the list of the most volatile stocks — is APEX BIOTECHNOLOGY CORP there?
Today APEX BIOTECHNOLOGY CORP has the market capitalization of 3.01 B, it has increased by 3.79% over the last week.
Yes, you can track APEX BIOTECHNOLOGY CORP financials in yearly and quarterly reports right on TradingView.
APEX BIOTECHNOLOGY CORP is going to release the next earnings report on Mar 18, 2025. Keep track of upcoming events with our Earnings Calendar.
1733 net income for the last quarter is 33.07 M TWD, while the quarter before that showed 27.29 M TWD of net income which accounts for 21.20% change. Track more APEX BIOTECHNOLOGY CORP financial stats to get the full picture.
Yes, 1733 dividends are paid annually. The last dividend per share was 1.10 TWD. As of today, Dividend Yield (TTM)% is 3.65%. Tracking APEX BIOTECHNOLOGY CORP dividends might help you take more informed decisions.
APEX BIOTECHNOLOGY CORP dividend yield was 2.73% in 2023, and payout ratio reached 94.96%. The year before the numbers were 5.48% and 76.97% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. APEX BIOTECHNOLOGY CORP EBITDA is 185.91 M TWD, and current EBITDA margin is 12.97%. See more stats in APEX BIOTECHNOLOGY CORP financial statements.
Like other stocks, 1733 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade APEX BIOTECHNOLOGY CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So APEX BIOTECHNOLOGY CORP technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating APEX BIOTECHNOLOGY CORP stock shows the neutral signal. See more of APEX BIOTECHNOLOGY CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.